Abstract:In the situation of Coronavirus disease 2019 (COVID-19), forecasting disease progression and identifying therapeutic drug targets is critical, especially given the nonattendance of a viable approach for treating severe cases. The preparation cohort revealed promising biomarkers, which were then precisely measured and employed to assess prediction accuracy across validation cohorts. This approach holds significant potential in enhancing understanding of severe COVID-19 and aiding the development of effective treatments. However, ultrasound-guided MRI (US-MRI) is an emerging modality that can noninvasively acquire multi-parametric information on COVID-19 and function without the need for contrast agents. This shows that neural network analysis of US-MRI transports exclusive prognosis data and this significantly improved prognosis performance. Consequently, the research proposed a deep neural network model of an Ensemble Multi-Relational Graph Neural Network (EMR-GNN) to determine the optimal model for predicting vascular biomarkers (CRP, IL-6, ferritin). In the nonappearance of a tailored treatment for this emerging virus, scientists are actively investigating various strategies to curb its replication. This work focuses on identifying potential drug targets, drawing from proteins abundant in lung material and those targeted by FDA-approved drugs as catalogued in HPA. This effort reflects a broader initiative within the methodical unrestricted to develop effective means of limiting virus replication. Accordingly, recognized five lung-improved proteins, comprising MRC1, SG3A1, CCL18, histone H4, and CLEC3B, were annotated as “drug targets”. For this, the researcher proposes a Heterogeneous Graph Structural Attention Neural Network (HGS-ANN) model to learn topological information of composite molecules and a Dilated Causal CNN-LSTM model with U-Net layers for modelling spatial-sequential information in Simplified Molecular-Input Line-Entry System (SMILES) sequences of drug data. The COVID-19 datasets are downloaded from the GEO database. These data are evaluated using Matlab software. The proposed work evaluated that the AUC of the work is 0.995, however, the AUC is measured based on sex, age, and chronic diseases. This model has a 0.933 accuracy in the subgroup of slices thicker than 1mm. However, the AUC curve and the classification outcome of the proposed method are compared with the existing rad model, deeper, and KNN models. In comparison to existing methods, the proposed model demonstrates superior performance. This research not only identifies potential therapeutic targets nonetheless also serves to uncover biomarkers crucial for comprehending the pathogenesis of undecorated COVID-19.

Graph Attention Network-Based Prediction of Drug-Gene Interactions of Signal Transducer and Activator of Transcription (STAT) Receptor in Periodontal Regeneration

Comparing Graph Sample and Aggregation (SAGE) and Graph Attention Networks in the Prediction of Drug-Gene Associations of Extended-Spectrum Beta-Lactamases in Periodontal Infections and Resistance

drGAT: Attention-Guided Gene Assessment of Drug Response Utilizing a Drug-Cell-Gene Heterogeneous Network

GATher: Graph Attention Based Predictions of Gene-Disease Links

Graph Neural Network-Based Drug Gene Interactions of Wnt/β-Catenin Pathway in Bone Formation

Drug-Target Interaction Prediction with Graph Attention networks

GCNGAT: Drug–disease association prediction based on graph convolution neural network and graph attention network

BiTGNN: Prediction of drug–target interactions based on bidirectional transformer and graph neural network on heterogeneous graph

LaGAT: link-aware graph attention network for drug–drug interaction prediction

Graph Convolutional Autoencoder and Generative Adversarial Network-Based Method for Predicting Drug-Target Interactions

Protein-ligand Binding Affinity Prediction Model Based on Graph Attention Network

A Multi-Omics Integration Framework Using Graph Attention Networks for Cancer Subtype Prediction

EPGAT: Gene Essentiality Prediction With Graph Attention Networks

Predicting drug–protein interactions by preserving the graph information of multi source data

Cross-tissue Graph Attention Networks for Semi-supervised Gene Expression Prediction

Prediction of drug-likeness using graph convolutional attention network

Prediction of Covid-19 Multiparametric Biomarkers and Drug Target of Patients for Risk Stratification Using Machine Learning Approach

Hierarchical and dynamic graph attention network for drug-disease association prediction

Prediction of Interactomic HUB Genes in Periodontitis With Acute Myocardial Infarction

GPCNDTA: Prediction of drug-target binding affinity through cross-attention networks augmented with graph features and pharmacophores

Analysis of Gene Regulatory Networks from Gene Expression Using Graph Neural Networks